Acupath First Commercial Lab to Offer URO17™, Innovative New Biomarker

July 25, 20190

PLAINVIEW, N.Y. and CAMPBELL, Calif., July 25, 2019 /PRNewswire/ — Acupath Laboratories, Inc., a leading provider of sub-specialized anatomic and molecular pathology services, and KDx Diagnostics, Inc., a leading developer of bladder cancer tests, today announced that KDx has licensed Acupath to incorporate its URO17™ … Read More

Leave a Reply

Your email address will not be published. Required fields are marked *